AU:AFP Stock Latest News
Company AnnouncementsAFT Pharmaceuticals posts strong 1H growth and deepens global R&D pipeline3w ago
Company AnnouncementsAFT Pharmaceuticals licenses Maxigesic IV to Mikasa for Japanese market push1M ago
Company AnnouncementsAFT Pharmaceuticals Shareholders Back Board at 2026 AGM3M ago
Company AnnouncementsAFT Pharmaceuticals Chair David Flacks to Step Down After Steering Years of Strong Growth3M ago
Company AnnouncementsAFT Pharmaceuticals posts record year, lifts dividend and maps next growth phase3M ago
Company AnnouncementsAFT Pharmaceuticals touts R&D pipeline with multi-billion-dollar market reach3M agoCompany AnnouncementsAFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.3M ago
Company AnnouncementsAFT Pharmaceuticals Targets IV Iron Market With New Phase III Anemia Trial3M agoAFP
Company AnnouncementsAFT Pharmaceuticals Flags Strong Growth as Injectables Pipeline Advances3M ago
Company AnnouncementsAFT Pharmaceuticals Sets 31 July Date for 2026 Annual Meeting4M ago
Company AnnouncementsAFT Pharmaceuticals Targets Youth Pain Market With New Combogesic Trial4M agoAFP
Company AnnouncementsAFT Pharmaceuticals Advances Pediatric IV Pain Study With Combogesic®4M agoAFP
Company AnnouncementsAFT Pharmaceuticals Lifts Total Dividend for FY20265M ago
Company AnnouncementsAFT Pharmaceuticals Sets July Date and Nomination Deadline for 2026 AGM5M ago
Company AnnouncementsAFT Pharmaceuticals Grants New Performance-Linked Employee Share Options5M ago
Company AnnouncementsAFT Pharmaceuticals posts record profit on global expansion and R&D push5M ago
Company AnnouncementsAFT Pharmaceuticals Declares Fully Imputed FY26 Final Dividend5M agoCompany AnnouncementsAFT Pharmaceuticals schedules FY2026 results release and investor webcast5M ago



